rejoy-heath-logo
    • RejoyGPT
    • AI Scribe
    • AI Coder
    • AI Receptionist
    • AI Interpreter
    • Clinical Decision Support
    • Medical Search
  • Features
  • Pricing
Request a Demo

Products

  • RejoyGPT
  • AI Scribe
  • AI Coder
  • AI Receptionist
  • AI Interpreter
  • Clinical Decision Support
  • Medical Search
  • Features
  • Pricing
Request a Demo
rejoy-heath-logo
    • RejoyGPT
    • AI Scribe
    • AI Coder
    • AI Receptionist
    • AI Interpreter
    • Clinical Decision Support
    • Medical Search
  • Features
  • Pricing
Request a Demo

Products

  • RejoyGPT
  • AI Scribe
  • AI Coder
  • AI Receptionist
  • AI Interpreter
  • Clinical Decision Support
  • Medical Search
  • Features
  • Pricing
Request a Demo
rejoy-heath-logo
Company

The AI care team for clinics and hospitals. Scribe, coder, reception, interpretation, and clinical answers in one suite. You stay in charge.

Contact
Click here to
Contact Support
on WhatsApp

600 California St,

San Francisco, CA 94108

hello@rejoyhealth.com
AI care team
RejoyGPTAI ScribeAI CoderAI ReceptionistAI InterpreterClinical Decision SupportMedical Search
Resources
ResourcesQuestion BankContestsCommunityBlogSearch SymptomsSearch CalculatorsSearch DrugsSymptom CheckerPricing
Terms and conditions
Privacy policyTerms of Service
Published on November 7, 2026

Forever Chemicals and Breast Cancer: New Research Raises Concerns About PFOA and PFOS Exposure

Now Hiring · Rejoy Health Team

We're hiring AI Trainers. Remote, contract, $75 to $100 +/hr.

Help train and evaluate the models behind Rejoy Health. No medical or technical background needed. If you write clearly in English, Spanish, French, or another language, we want to hear from you. Work remotely, on your own schedule.

View the role

Breast cancer remains one of the most significant health challenges affecting women worldwide. While genetics, lifestyle, and hormonal factors have long been recognized as contributors to breast cancer risk, scientists are increasingly investigating environmental pollutants that may play a role in cancer development. A recent federal study has added to growing concerns by identifying a possible link between two widely known "forever chemicals" and an increased risk of aggressive breast cancer.

The findings have renewed discussions about the long-term health effects of per- and polyfluoroalkyl substances (PFAS), particularly two compounds called perfluorooctanoic acid (PFOA) and perfluorooctanesulfonic acid (PFOS).

What Are Forever Chemicals?

PFAS are a large group of synthetic chemicals that have been used in industrial processes and consumer products for decades. These substances gained popularity because of their resistance to heat, water, and oil. They have been found in products such as non-stick cookware, stain-resistant fabrics, food packaging, firefighting foams, and industrial manufacturing materials.

The term "forever chemicals" comes from their remarkable persistence in the environment and the human body. Unlike many compounds that break down naturally over time, PFAS can remain in soil, water, and biological tissues for years or even decades.

Among the thousands of PFAS compounds, PFOA and PFOS are the most extensively studied. Although production of these chemicals has largely been phased out in the United States, they continue to be detected in water supplies and environments around the world due to their long-lasting nature.

The New Study's Key Findings

Researchers examined blood samples and health records from thousands of women to investigate whether PFAS exposure may influence breast cancer risk. The study analyzed data from 1,609 women diagnosed with breast cancer and compared them with 2,269 women who did not develop the disease.

The results revealed a concerning trend. Women with the highest levels of PFOA in their blood were found to have a 67% greater risk of developing estrogen receptor-negative (ER-negative) breast cancer compared with those who had the lowest levels of exposure.

Similarly, women with the highest concentrations of PFOS experienced a 93% higher risk of developing the same aggressive form of breast cancer.

These findings suggest that elevated exposure to specific PFAS chemicals could be associated with a significantly increased risk of ER-negative breast cancer, a subtype known for being more difficult to treat.

Understanding ER-Negative Breast Cancer

Breast cancers are often classified based on whether cancer cells possess hormone receptors for estrogen or progesterone. These receptors can influence how tumors grow and respond to treatment.

Hormone receptor-positive cancers often respond well to therapies that block or reduce hormone activity. These treatment options can slow tumor growth and improve outcomes.

ER-negative breast cancers, however, do not contain estrogen receptors. As a result, hormone-based therapies are generally ineffective. These cancers often grow more rapidly, may spread more aggressively, and can present greater treatment challenges.

According to the National Cancer Institute, ER-negative breast cancers account for approximately 15% of all breast cancer cases. Despite representing a minority of diagnoses, they are often associated with poorer outcomes compared with hormone-responsive cancers.

How Might PFAS Influence Cancer Risk?

Researchers have not yet established exactly how PFOA and PFOS contribute to cancer development. However, the latest findings suggest that the mechanism may differ from traditional hormone-related pathways.

Since ER-negative cancers do not rely on estrogen signaling, scientists believe PFAS may influence cancer risk through alternative biological processes. Potential mechanisms include:

Immune System Disruption

The immune system plays a vital role in identifying and eliminating abnormal cells before they develop into cancer. Some studies suggest PFAS exposure may interfere with immune system function, potentially reducing the body's ability to suppress tumor formation.

Changes in Gene Expression

Environmental chemicals can sometimes alter how genes are activated or silenced. Researchers suspect PFAS exposure could affect genes involved in cell growth, repair, and cancer progression.

Chronic Inflammation

Long-term exposure to environmental pollutants has been linked to persistent inflammation, which may create conditions favorable for cancer development.

While these mechanisms remain under investigation, scientists agree that further research is necessary to fully understand the biological pathways involved.

Why This Research Matters

Breast cancer is already the most common cancer affecting women aside from skin cancers. In the United States alone, more than 42,000 women are expected to die from breast cancer each year.

At the same time, PFAS contamination has become a widespread environmental concern. Testing by regulatory agencies has identified PFOA, PFOS, or related PFAS compounds in hundreds of public water systems.

Because exposure often occurs through drinking water, millions of people could potentially come into contact with these chemicals over long periods.

The new findings do not prove that PFAS directly cause breast cancer. However, they strengthen concerns about the potential health consequences of long-term exposure and highlight the importance of continued monitoring and scientific investigation.

Practical Steps to Reduce Exposure

Although eliminating PFAS exposure entirely can be difficult, individuals can take several measures to reduce their risk.

Check Local Water Quality

Contact your local water supplier to determine whether PFAS testing has been conducted. Many utilities now provide water quality reports that include information about PFAS contamination.

Use Certified Water Filtration Systems

Not all household water filters remove PFAS effectively. Consumers should look for systems certified by the National Sanitation Foundation (NSF) or other recognized testing organizations for PFAS reduction.

Common effective options include:

  • Reverse osmosis systems
  • Activated carbon filtration units
  • Specialized PFAS-removal filters

Stay Informed About Environmental Risks

Government agencies, universities, and public health organizations increasingly publish PFAS monitoring data. Reviewing these resources can help individuals understand potential exposure levels in their communities.

Discuss Testing With Healthcare Providers

In areas known for elevated PFAS contamination, healthcare professionals may recommend blood testing or additional monitoring. Individuals concerned about their exposure should discuss available options with qualified medical practitioners.

The Need for Further Research

Researchers emphasized that additional studies are required to evaluate the health effects of both legacy PFAS chemicals and newer replacement compounds that have entered the market.

Future investigations may focus on populations with exceptionally high levels of exposure and demographic groups that already experience higher rates of ER-negative breast cancer.

Understanding these relationships could help improve prevention strategies, environmental regulations, and public health recommendations in the years ahead.

Conclusion

The latest research linking elevated blood levels of PFOA and PFOS to aggressive ER-negative breast cancer adds to growing evidence that environmental contaminants may significantly influence human health. While scientists have not yet established a direct cause-and-effect relationship, the findings highlight the importance of continued PFAS monitoring, exposure reduction, and long-term research.

As awareness of forever chemicals continues to grow, individuals, healthcare providers, regulators, and researchers must work together to better understand the risks and identify effective strategies for protecting public health.

Source

The Independent, 6 November 2026.

Disclaimer

This article is intended for informational and educational purposes only. It does not constitute medical advice, diagnosis, or treatment. Individuals concerned about breast cancer risk, PFAS exposure, or environmental health issues should consult qualified healthcare professionals and relevant public health authorities for personalized guidance.

Now Hiring · Rejoy Health Team

Speak English, Spanish, or French? Get paid to train AI.

Rejoy Health is looking for AI Trainers to review model responses, write reference answers, and flag replies that are confusing or unhelpful. You will shape how millions of people receive health information, one careful judgement at a time. There is no degree, medical background, or coding experience required. If you can read and write well in English, Spanish, French, or another language, you can do this work. Remote and contract, $75 to $100+/hr, with hours that fit around study, work, or family commitments.

Apply today

Share this post

Explore Related Articles for Deeper Insights

Pharmacists Warn Against Putting Allergy Tablets in the Vagina: Risks and Facts
Pharmacists warn women against inserting cetirizine allergy tablets into the vagina. Discover the ri...
View article →
Gearharts Fine Chocolates Recall: Glass Contamination Affects 17 States
Gearharts Fine Chocolates recalls 4,703 chocolate pieces in 17 states after glass was found in the p...
View article →
Psilocybin and Alzheimer’s Disease: Can Magic Mushrooms Help Restore Memory and Communication?
Alzheimer’s disease is widely regarded as a progressive neurodegenerative condition that gradually e...
View article →

To get more personalized answers,
download now

Login
Register